Orchid Pharma completes USFDA inspection at Alathur API facility with seven minor observations
The facility remains India’s only USFDA-approved site for Sterile Cephalosporins and secures EU GMP certification renewal
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Orchid Pharma
Industry leaders share their expectations from Budget 2025-26
Experts aim for the budget to include benefits for the Nutraceuticals sector, incentives for CROs and expansion of the PLI scheme…
Antimicrobial Resistance and innovations shaping our future
Dr Prabhu Vinayagam, Medical Advisor, and Dr Girija Kishore, Clinical Resource Consultant - North, from Orchid AMS (Division of…
Orchid Pharma appoints new leaders for antimicrobial stewardship division
Dr Prabhu Vinayagam appointed as Medical Advisor; Amitabh Mazumdar Joins as GM-Sales & Marketing
Orchid Pharma, Cipla to launch antibiotic Cefepime-Enmetazobactam in India
This alliance aims to rapidly deploy Orchid’s novel anti-infective invented in India to address the rising threat of antimicrobial…
Rajnish Rohatgi appointed as CEO of Orchid AMS
He will be responsible for setting up a new division focused on promoting the rational use of anti-infectives and to favourably…
Orchid Pharma receives DCGI approval for its antibiotic drug combination of Cefepime and…
Its reportedly company’s first invented and made-in-India drug
Orchid Pharma, has received Drugs Controller General of India…
Orchid Pharma gets USFDA approval for Exblifep
Enmetazobactam is the first completely invented-in-India Beta Lactamase Inhibitor
Orchid Pharma gets EMA approval for Exblifep
Exblifep has received EMA's recommendation for marketing authorization for use in treatment of complicated urinary tract…
NCLT approves Dhanuka’s resolution plan for Orchid Pharma
According to the Dhanuka plan, the creditors will get around Rs 1,116 crore including Rs 570 crore quoted by Dhanuka Lab. Orchid’s…